This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PUN, K. K. Articles by HO, P. W. M. Search for Related Content PubMed PubMed Citation Articles by PUN, K. K. Articles by HO, P. W. M.

The Use of Glucagon Challenge Tests in the Diagnostic Evaluation of Hypoglycemia due to Hepatoma and Insulinoma^*

K. K. PUN, R. T. T. YOUNG, C. WANG, C. F. TAM and P. W. M. HO

Department of Medicine, University of Hong Kong, Queen Mary Hospital Hong Kong

We previously found that patients with hypoglycemia due to chronic renal and liver disease had anomalous metabolic responses to glucose and glucagon stimulation. In this study we evaluated the use of glucagon (2 mg, iv) tests in the diagnosis of spontaneous hypoglycemia secondary to hepatocellular carcinoma (HCC) and insulinoma. Twenty-one normal subjects, 45 patients with HCC (11 with hypoglycemia), and 14 patients with insulinoma (all with hypoglycemia) were studied. The fasting blood glucose level was low in all patients with hypoglycemia. The fasting plasma insulin and C-peptide concentrations were high in patients with insulinoma and low in patients with HCC and hypoglycemia. The blood glucose responses to glucagon administration were less than normal in patients with HCC and hypoglycemia and within normal limits in patients with insulinoma.

The insulinoma patients had increased plasma insulin and Cpeptide responses to glucagon despite having low blood glucose levels. Compared with the HCC patients without hypoglycemia, HCC patients with hypoglycemia had impaired plasma insulin and C-peptide responses. The fasting hypoglycemia, hypoinsulinemia, and impaired insulin/C-peptide responses to glucagon in patients with hepatoma and hypoglycemia presumably reflect the production of insulin-like substances by the hepatoma. We conclude that glucagon administration results in characteristic responses in these groups of patients and can be of use in the diagnosis of spontaneous hypoglycemia secondary to hepatoma or insulinoma.

^* This work was supported by University of Hong Kong Research Grants 335/041/0016 and 331/030/8010/57, Faculty of Medicine, University of Hong Kong (to K.K.P.).

To whom all correspondence and requests for reprints should be addressed.

Received October 2, 1987.

This article has been cited by other articles:

				J. B. Kruskal and R. A. Kane Paraneoplastic Hypoglycemia Associated With a Hepatic Hemangiopericytoma J. Ultrasound Med., August 1, 2002; 21(8): 927 - 932. [Full Text] [PDF]